Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reducing the Impact of Ovarian Stimulation - The RIOT Project. Study RIOT-A: The Role of Aromatase Inhibitor in Reducing the Detrimental Effects of Ovarian Stimulation to Optimize Outcomes in Fresh Embryo Transfer Cycles

NCT02946684 is registered in ClinicalTrials.gov with Sven O. Skouby as lead sponsor.

NCT NCT02946684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02946684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reducing the Impact of Ovarian Stimulation - The RIOT Project. Study RIOT-A: The Role of Aromatase Inhibitor in Reducing the Detrimental Effects of Ovarian Stimulation to Optimize Outcomes in Fresh Embryo Transfer Cycles
Lead sponsor
Sven O. Skouby
Phase
Phase 2/3
Overall status
Completed
Start date
February 1, 2017
Completion date
October 30, 2018
Enrollment
129 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

infertility